𝔖 Bobbio Scriptorium
✦   LIBER   ✦

5-AZA-2′-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation

✍ Scribed by Richard L. Momparler; Jacques Bouchard; Nicole Onetto; Georges E. Rivard

Book ID
113238337
Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
324 KB
Volume
8
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of decitabine (5-aza-2′deoxycyti
Results of decitabine (5-aza-2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia
✍ Hagop M. Kantarjian; Susan O'Brien; Jorge Cortes; Francis J. Giles; Stefan Fader 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## BACKGROUND General and site‐specific DNA methylation is associated with tumor progression and resistance in several cancers, including chronic myelogenous leukemia (CML). Decitabine is a hypomethylating agent that has shown encouraging preliminary anti‐CML activity. This study evalu

Phase I study on 5-aza-2′-deoxycytidine
Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia
✍ Georges E. Rivard; Richard L. Momparler; Jocelyn Demers; Paul Benoit; Richard Ra 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 709 KB

Ahstract--A Phase I study with 5-aza-2'-deoxycytidine (5-AZA-CdR) was performed on children with acute leukemia who were resistant to conventional chemotherapy. The objective of this study was to find the dose-schedule of 5-AZA-CdR that produced a potent antileukemic effect and to evaluate its toxic

[Medical Intelligence Unit] DNA Methylat
[Medical Intelligence Unit] DNA Methylation and Cancer Therapy || Preclinical and Clinical Studies on 5-Aza-2′-Deoxycytidine, a Potent Inhibitor of DNA Methylation, in Cancer Therapy
✍ Momparler, Richard L. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 872 KB

Dna Methylation : Three Decades In Search Of Function / Aharon Razin -- Epigenetic Mechanisms Of Gene Regulation : Relationships Between Dna Methylation, Histone Modification, And Chromatin Structure / Keith D. Robertson -- Dna Hypo- Vs. Hypermethylation In Cancer : Tumor Specificity, Tumor Progress